• eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

    14 hours ago

  • AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies

    14 hours ago

  • Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial

    1 day ago

  • Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

    1 day ago

  • Mithra's exclusivity on Estetrol applications extended to 2036 in Europe

    1 day ago

  • flanders.bio job board increasingly popular

    Thursday November 26th 2020

  • Estetrol recognized as a "New Active Substance" by the European Medicines Agency (EMA)

    Wednesday November 25th 2020

  • Novalis Biotech Announces First Closing of its Second Healthcare Fund

    Tuesday November 24th 2020

  • Your news here?

  • Selvita to acquire Fidelta from Galapagos

    Tuesday November 24th 2020

  • Qarad opent nieuw kantoor in VK

    Tuesday November 24th 2020

  • argenx Enters Into Agreement To Acquire Priority Review Voucher

    Monday November 23rd 2020


Strategic Partners